TNFRSF17 and Miyoshi myopathy: The addition of a gamma secretase inhibitor in vitro enhances BCMA BsAb-induced MM cell killing, with rapid clearance of circulating sBCMA, enhanced tumour control, and improved survival demonstrated in a murine model [76].